Enveric Biosciences Announces Presentation of Two Posters at Canadian Chemical Engineering Conference (CSChE 2023) Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of…
Gardiner Healthcare Acquisitions Corp. (the “Company”) announced today that it intends to deposit, or have deposited, into the Company’s trust account the amount of $100,000 in order to extend the…
Sonendo, Inc. (NYSE: SONX) (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today announced that, on November 15, 2023, it received a notice…
RootPath announced today the US launch of its flagship product, RootPath Custom Gene Library. Similar to conventional gene synthesis products, this product is delivered as individual, sequence-verified plasmids in 96-…
Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), today announced The Lancet Neurology published online preliminary results of a clinical trial conducted by Astellas Pharma using…
Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, has successfully completed the world’s first-in-human case utilizing its newest donor lung preservation technology, the BAROguard™ Donor Lung…
Avistone Announces the First Approval of Vebreltinib for MET Exon 14 Skipping Non-Small Cell Lung Cancer Opening a New Chapter in MET-targeted Treatment of Lung Cancer Avistone Biotechnology Co. Ltd.…
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced…
SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed…
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders…
BeautyHealth Announces Leadership Transition The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced that Andrew Stanleick will depart the Company as President & Chief Executive Officer and…
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2023 Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that…